ask="N/A"
ask_size="N/A"
average_daily_volume="422123"
bid="20.30"
bid_size="500"
book_value="8.12"
change="+0.13"
change_from_200_day_moving_average="0.97"
change_from_50_day_moving_average="0.97"
change_from_52_week_high="-3.43"
change_From_52_week_low="9.54"
change_in_percent="+0.62%"
close="21.14"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="-18.48M"
eps_estimate_current_year="-0.11"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-0.01"
ex_dividend_date="N/A"
float_shares="21579000"
high="21.25"
high_52_weeks="24.57"
last_trade_date="3/6/2017"
last_trade_price="21.14"
last_trade_size="17846"
last_trade_time="4:00pm"
low="20.50"
low_52_weeks="11.60"
market_capitalization="805.29M"
moving_average_200_day="20.17"
moving_average_50_day="20.17"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="33.33"
open="20.77"
pe_ratio="N/A"
peg_ratio="-9.81"
percent_change_from_200_day_moving_average="+4.79%"
percent_change_from_50_day_moving_average="+4.81%"
percent_change_from_52_week_high="-13.96%"
percent_change_from_52_week_low="+82.24%"
previous_close="21.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.59"
price_per_sales="5.99"
revenue="133.59M"
shares_outstanding="38093000"
short_ratio="16.58"
stock_exchange="NGM"
symbol="RTRX"
volume="443655"
weeks_range_52="11.60 - 24.57"
